Dr. Santiago Munoz, MD

Dr. Munoz practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Munoz's NPI, 1578531190, was assigned on March 9, 2006. Dr. Munoz holds New Jersey license 25MA0834100.

Dr. Munoz's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Munoz's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Munoz is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Munoz to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Munoz practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Munoz's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Munoz's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 187 Medicare services from Dr. Munoz across 6 procedure codes in 2024, for 113 Medicare patients. Medicare paid $21,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Dr. Munoz in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Munoz's median patient age at 67, with 43% women.

In 2024, Dr. Munoz wrote 89 Medicare Part D claims for 30 patients. 83% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $1,724 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Munoz for performance year 2024, reported as part of a group.

CMS Open Payments shows 1,164 general payments to Dr. Munoz from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Madrigal Pharmaceuticals paid the most, $357,859.